Life expectancy for severe cervical precancer

Cervical precancerous lesions are highly aggressive tumor diseases that seriously endanger women's health. Therefore, how long can a patient with cervical precancerous lesions live is a question that every patient and their family members are eager to know. In fact, there is no definite answer to the question of how long a patient with cervical precancerous lesions can live. This is closely related to the physical condition of each patient. If it can be detected in the early stage and treated actively, the life span can be extended or even cured.

According to relevant information, the cure rate for the initial stage of cervical precancerous lesions can reach 80 to 90 percent, 60 to 70 percent for stage 2, and 40 to 50 percent for stage 3. However, it is only 10 percent when it develops to stage 4. Therefore, regular examinations and timely treatment are very important.

How long can you live with cervical precancerous lesions? The survival period of patients with cervical precancerous lesions mainly depends on whether the treatment method is appropriate and the patient's physical function. Whether the treatment method is appropriate is the most important factor affecting how long patients with cervical precancerous lesions can live. In addition, the patient's physical function is good and the immunity is strong to resist the development of cancer and tolerate various treatments. Currently, the clinical commonly used treatment is a comprehensive therapy of biological cell immunotherapy combined with surgery, radiotherapy and chemotherapy.

How long can you live with cervical precancerous lesions? Clinically, the treatments for cervical precancerous lesions mainly include radiotherapy, chemotherapy and surgery. The method of radiotherapy varies depending on the specific situation of the patient, and it is often combined with internal and external radiation. Chemotherapy often uses combined radiotherapy. As the duration of chemotherapy increases, the toxicity of treatment is also gradually increasing. Therefore, the chemotherapy drugs and chemotherapy time should be determined based on the tumor remission, symptom remission and treatment-related toxicity.